Researchers pursue novel therapeutic targets for inflammatory bowel disease

Posted on by

There is currently no cure for inflammatory bowel disease (IBD), which affects 2.5 million people across Europe and is increasing globally with industrialisation. It is a chronic condition with a high burden of symptoms, and severely affected people may require removal of part of the colon to control the impact of disease.

A group of University of Birmingham research scientists has received a prestigious Innovators Award from US-based Kenneth Rainin Foundation to fund foundational research in IBD. The Innovators Award will enable the research group to investigate a promising new therapeutic target that has already been identified and patented by University of Birmingham Enterprise.Read more…